← FDA DRUG APPROVALS

FDA ANDA · ANDA205780

VANCOMYCIN HYDROCHLORIDE

Sponsor: EUGIA PHARMA

APPLICATION
ANDA205780
TYPE
ANDA
ORIGINAL APPROVAL
2016-03-31
LATEST ACTION
2020-08-17
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

VANCOMYCIN HYDROCHLORIDEPrescription
VANCOMYCIN HYDROCHLORIDE EQ 1GM BASE/VIAL · INJECTABLE · INJECTION
VANCOMYCIN HYDROCHLORIDEPrescription
VANCOMYCIN HYDROCHLORIDE EQ 500MG BASE/VIAL · INJECTABLE · INJECTION

Approval history

2020-08-17Labeling · Supplement 2 · standardAP
2020-08-17Labeling · Supplement 1 · standardAP
2016-03-31UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →